These results supported our hypothesis that our dimers could target CCNA2 to inhibit SARC by affecting tumor immunity, proliferation, and apoptosis in MG-63 cells.CCNA2 could interact with CDK2 to initiate the cell cycle in vivo (38). This evidence concerns the gene CCNA2 and neoplasm.